3-aminobenzamide has been researched along with Body Weight in 7 studies
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
Excerpt | Relevance | Reference |
---|---|---|
" In vivo treatment with ip administration of 3-aminobenzamide (10 mg/kg, 1 and 6 hrs after zymosan injection) or nicotinamide (50 mg/kg, 1 and 6 hrs after zymosan injection) significantly decreased mortality, inhibited the development of peritonitis, and reduced peroxynitrite formation." | 3.70 | Protective effect of poly(ADP-ribose) synthetase inhibition on multiple organ failure after zymosan-induced peritonitis in the rat. ( Caputi, AP; Costantino, G; Cuzzocrea, S; Sottile, A; Teti, D; Zingarelli, B, 1999) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 3 (42.86) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cuzzocrea, S | 1 |
Zingarelli, B | 1 |
Costantino, G | 1 |
Sottile, A | 1 |
Teti, D | 1 |
Caputi, AP | 1 |
Tsujiuchi, T | 2 |
Mizumoto, K | 1 |
Tsutsumi, M | 2 |
Denda, A | 2 |
Amanuma, T | 2 |
Kondoh, S | 2 |
Konishi, Y | 2 |
Kamino, K | 1 |
Pan, QC | 1 |
Guo, HY | 1 |
Cardinale, A | 1 |
Paldino, E | 1 |
Giampà, C | 1 |
Bernardi, G | 1 |
Fusco, FR | 1 |
Choi, SK | 1 |
Galán, M | 1 |
Kassan, M | 1 |
Partyka, M | 1 |
Trebak, M | 1 |
Matrougui, K | 1 |
Szabó, C | 1 |
Biser, A | 1 |
Benko, R | 1 |
Böttinger, E | 1 |
Suszták, K | 1 |
7 other studies available for 3-aminobenzamide and Body Weight
Article | Year |
---|---|
Protective effect of poly(ADP-ribose) synthetase inhibition on multiple organ failure after zymosan-induced peritonitis in the rat.
Topics: Animals; Benzamides; Body Weight; Disease Models, Animal; Drug Evaluation, Preclinical; Male; Multip | 1999 |
Effects of 3-aminobenzamide on the post-initiation phase of N-nitrosobis(2-oxopropyl)amine induced pancreatic carcinogenesis in Syrian hamsters.
Topics: Animals; Benzamides; Body Weight; Carcinogens; Cricetinae; Dose-Response Relationship, Drug; Eating; | 1991 |
Effects of 3-aminobenzamide on induction of multiorgan carcinogenesis by N-nitrosobis(2-hydroxypropyl)amine in hamsters.
Topics: Animals; Benzamides; Body Weight; Carcinogens; Cricetinae; Liver; Liver Neoplasms, Experimental; Lun | 1991 |
The potentiation of the antitumor activity but not toxicity of bleomycin by 3-aminobenzamide.
Topics: Animals; Benzamides; Bleomycin; Body Weight; Dose-Response Relationship, Drug; Drug Synergism; Hydro | 1989 |
PARP-1 Inhibition Is Neuroprotective in the R6/2 Mouse Model of Huntington's Disease.
Topics: Animals; Blotting, Western; Body Weight; Brain-Derived Neurotrophic Factor; Corpus Striatum; Cyclic | 2015 |
Poly(ADP-ribose) polymerase 1 inhibition improves coronary arteriole function in type 2 diabetes mellitus.
Topics: Animals; Benzimidazoles; Blood Glucose; Blood Pressure Determination; Blotting, Western; Body Weight | 2012 |
Poly(ADP-ribose) polymerase inhibitors ameliorate nephropathy of type 2 diabetic Leprdb/db mice.
Topics: Animals; Apoptosis; Blood Pressure; Body Weight; Diabetes Mellitus, Type 2; Diabetic Nephropathies; | 2006 |